Differential Effects of Morning or Evening Dosing of Amlodipine on Circadian Blood Pressure and Heart Rate

Cardiovascular Drugs and Therapy

Volumn 17, Issue 4, 2003, Pages 335-341

  Qiu, Yuan Gang ^a   Chen, Jun Zhu ^a   Zhu, Jian Hua ^a   Yao, Xue Yan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Ambulatory blood pressure monitoring; Amlodipine; Circadian rhythm; Hypertension; Morning and evening administration

Indexed keywords

AMLODIPINE; PLACEBO;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AMLODIPINE; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED;

EID: 0344197474     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027347723347     Document Type: Article

References (31)

1. Prisant LM. Hypertension and chronotherapy: Shifting the treatment paradigm. Am J Hypertens 2001;14:277s-279s.
2. White WB. A chronotherapeutic approach to the management of hypertension. Am J Hypertens 1996;10:29s-32s.
3. Lemmer B. Differential effects of antihypertensive drugs on circadian rhythm in blood pressure from chronobiologic point of view. Blood Press Monitor 1996;1:161-169.
4. Palatini P, Racioppa A, Raule G, Zaninotto M, Penzo M, Pessina AC. Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther 1992;52:378-383.
5. Pickering TG, Levenstein M, Walmsley P. Night-time dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of HALT study. Am J Hypertens 1994;6:844-847.
6. Whelton A, Miller WE, Dunne B Jr, Hait HI, Tresznewsky ON. Once-daily lisinopril compared with twice-daily captopril in the treatment of mild-to-moderate hypertension, assessment of office and ambulatory blood pressure. J Clin Pharmacol 1990;30:1074-1080.
7. Abernathy DA. Pharmacokinetics and pharmacodynamics of amlodipine. Cardiology 1992;80(Suppl 1):31-36.
8. White WB. Methods of blood pressure determination to assure antihypertensive agent: Are causal measurements enough? Clin Pharmacol Ther 1989;45:581-586.
9. Coats AJ, Conway J, Somers VK, Isea JE, Sleight P. Ambulatory blood pressure monitoring in the assessment of antihypertensive therapy. Cardiovasc Drugs Ther 1989;3:303-311.
10. White WB, Mansoor GA, Pickering TG, et al. Differential effects of morning and evening closing of nisoldipine ER on circadian blood pressure and heart rate. Am J Hypertens 1999;12:806-814.
11. White WB. Circadian variation of blood pressure: Clinical relevance and implications for cardiovascular chronotherapeutics. Blood Press Monitor 1997;2:47-52.
12. Lemmer B, Portaluppi F. Chronopharmacology of cardiovascular disease. In: Redfern PH, Lemmer B, eds. Handbook of Experimental Pharmacology, Vol. 125, Physiology and Pharmacology of Biological Rhythms. Berlin: Springer-Verlag, 1997:251-297.
13. Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens 1997;15:205-211.
14. Witte K, Weisser K, Neubeck M, et al. Cardiovascular effects, pharmacokinetics and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther 1993;54:177-186.
15. Greminger P, Suter PM, Holm D, Kobelt R, Vetter W. Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin Invest 1994;72:864-869.
16. White WB, Mansoor GA, Tendler BE, Anwar VA. Nocturnal blood pressure epidemiology, determinant, and effects of antihypertensive therapy. Blood Press Monitor 1998;3:43-51.
17. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793-801.
18. Verdecchia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990;81:528-536.
19. Kuwajima I, Suzuki Y, Shimosawa T, Kanemaru A, Hoshino S, Kuramoto K. Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J 1992;67:1307-1311.
20. Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E. Relationship between initial cardiovascular structural changes and daytime and night-time blood pressure monitoring. Am J Hypertens 1992;5:180-186.
21. Pierdomenico SD, Lapenna D, Guglielmi MD, et al. Arterial disease in dipper and nondipper hypertensive patients. Am J Hypertens 1997;10:511-518.
22. Ferrara AL, Pasanisi F, Crivaro M, et al. Cardiovascular abnormalities in never-treated hypertensives according to nondiper status. Am J Hypertens 1998;11:1352-1357.
23. Smolensky MH, Haus E. Circadian rhythms and clinical medicine with applications to hypertension. Am J Hypertens 2001;14:280s-290s.
24. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly patients: Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996;27:130-135.
25. Watanabe N, Imai Y, Nagai K, et al. Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke 1996;27:1319-1327.
26. White WB, Dey HM, Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J 1989;118:782-795.
27. Sorof JM, Cardwell G, Franco K, Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 2002;39:903-908.
28. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566.
29. Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986;105:173-178.
30. Pfeffer M. Clinical implications of left ventricular hypertrophy in systemic hypertension. Cardiovasc Rev Rep Jan 1991:53-60.
31. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, and Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000;35:580-586.